United State

English

STAT News

STAT News

About: STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic. Our journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.
Contact Us: Email: first.opinion@statnews.com
Biden prostate cancer treatment: radiation and hormone therapy

Biden prostate cancer treatment: radiation and hormone therapy

Mass General Brigham turning to AI to ease primary care doctor shortage

Mass General Brigham turning to AI to ease primary care doctor shortage

Staff of CDC publication MMWR axed amid shutdown firings

Staff of CDC publication MMWR axed amid shutdown firings

CDC battered by government shutdown firings

CDC battered by government shutdown firings

What happens if a breast cancer patient refuses treatment?

What happens if a breast cancer patient refuses treatment?

President Trump is in 'exceptional health,' his doctor says

President Trump is in 'exceptional health,' his doctor says

Sarepta to seek approval for gene therapy in rare muscular dystrophy

Sarepta to seek approval for gene therapy in rare muscular dystrophy

Canadian lawmakers call on government to halt imports of long

Canadian lawmakers call on government to halt imports of long

Court allows generic version of Roche rare disease drug to be sold in India

Court allows generic version of Roche rare disease drug to be sold in India

HHS employees to be fired as White House enacts mass terminations again

HHS employees to be fired as White House enacts mass terminations again

AstraZeneca reaches deal with Trump on drug prices

AstraZeneca reaches deal with Trump on drug prices

AstraZeneca, BIOSECURE, Novo, Akero: Readout Newsletter

AstraZeneca, BIOSECURE, Novo, Akero: Readout Newsletter

Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

Pharmalittle: We're reading about U.S. Senate passing Biosecure Act, TrumpRx plans and more

Pharmalittle: We're reading about U.S. Senate passing Biosecure Act, TrumpRx plans and more

Bristol Myers to buy cell therapy startup Orbital for $1.5B

Bristol Myers to buy cell therapy startup Orbital for $1.5B

Senate passes BIOSECURE Act

Senate passes BIOSECURE Act

CHAI, Jay Shetty, autism misinformation: Morning Rounds

CHAI, Jay Shetty, autism misinformation: Morning Rounds

The overlapping narratives of Jay Shetty, monk turned mogul

The overlapping narratives of Jay Shetty, monk turned mogul

The system isn't designed to care for Alzheimer's patients like people

The system isn't designed to care for Alzheimer's patients like people

Debunking yet another RFK Jr. vaccine conspiracy theory

Debunking yet another RFK Jr. vaccine conspiracy theory

Trump officials take aim at Coalition for Health AI, as Amazon drops out

Trump officials take aim at Coalition for Health AI, as Amazon drops out

Top Democrat demands Medicare insurers disclose uses of AI in care

Top Democrat demands Medicare insurers disclose uses of AI in care

Readout LOUD podcast: Party in biotech land

Readout LOUD podcast: Party in biotech land

D.C. Diagnosis: Mike Johnson backs emergency care for immigrants

D.C. Diagnosis: Mike Johnson backs emergency care for immigrants

Blue Cross of Mass. offers buyouts as it faces financial woes

Blue Cross of Mass. offers buyouts as it faces financial woes

In biotech, Boston reigns supreme, but its competitive edge is being challenged

In biotech, Boston reigns supreme, but its competitive edge is being challenged

Akero, Novo, MASH, AstraZeneca, Roche: Readout Newsletter

Akero, Novo, MASH, AstraZeneca, Roche: Readout Newsletter

Pharmalittle: no Trump tariffs on generics, Novo's MASH deal

Pharmalittle: no Trump tariffs on generics, Novo's MASH deal

MacArthur genius, cannabis psychosis, CRISPR: Morning Rounds

MacArthur genius, cannabis psychosis, CRISPR: Morning Rounds

Novo Nordisk to buy Akero Therapeutics, picking up MASH drug

Novo Nordisk to buy Akero Therapeutics, picking up MASH drug